Mode
Text Size
Log in / Sign up

12-week home exercise intervention shows LDH reduction and high feasibility in myeloproliferative neoplasms patientsCan a simple home workout help patients with blood disorders feel better and move more freely?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider home-based exercise for myeloproliferative neoplasms; pilot data show LDH reduction and high feasibility.

This randomized controlled pilot trial assessed the feasibility, acceptability, and efficacy of a 12-week home-based exercise intervention among 55 patients with myeloproliferative neoplasms. The intervention comprised flexibility, resistance, and aerobic activities supervised by a kinesiologist, compared with a waitlist control group. The primary outcomes focused on feasibility benchmarks, while secondary outcomes included symptom burden, quality of life, and clinical inflammatory markers such as C-reactive protein, erythrocyte sedimentation rate, ferritin, lactate dehydrogenase (LDH), and serum cytokines.

Regarding efficacy, the study reported a significant reduction in LDH levels for patients in the intervention group compared with controls. Specifically, LDH decreased by 14.5 U/L versus an increase of 4.0 U/L in the control group, with a p-value of .03. Feasibility benchmarks were met by all participants. Satisfaction was high, with 88% of participants reporting satisfaction, and 92% expressed intent to continue a regular exercise program.

No adverse events, serious adverse events, discontinuations, or tolerability issues were reported. However, as a pilot study, these results require cautious interpretation. The study design and small sample size limit the ability to draw definitive conclusions regarding long-term efficacy or broader clinical applicability for myeloproliferative neoplasms management.

Many people living with myeloproliferative neoplasms face a tough reality: their bodies produce too many blood cells, leading to symptoms like extreme tiredness and pain that keep them from moving. For these patients, the idea of exercising often feels out of reach. But what if a simple, supervised routine right at home could change that? This pilot trial looked at exactly that possibility with 55 patients. They received a 12-week plan involving flexibility, resistance, and aerobic activities guided by a kinesiologist, while others waited for the program to start.

The results offered some encouraging signs. Participants who exercised saw a meaningful drop in lactate dehydrogenase, a marker linked to cell damage, compared to those on the waitlist. More importantly, 88% of them felt satisfied with the program, and 92% wanted to keep exercising regularly. The study also found no safety issues, with no serious side effects or dropouts reported during the trial.

However, we must be careful not to overstate what this means yet. Because this was a pilot study, it was designed to test if the program was feasible and acceptable, not to prove it cures the disease. The evidence is early, and larger studies are needed to confirm these benefits for a wider group of patients. Still, the message is clear: for some, a gentle home workout might be a safe and welcome step toward feeling better.

What this means for you:
A 12-week home exercise program was safe and well-accepted by patients with myeloproliferative neoplasms, showing early promise for improving blood markers and quality of life.

Study Details

Study typeRct
Sample sizen = 55
EvidenceLevel 2
Follow-up2.8 mo
PublishedApr 2026
View Original Abstract ↓
Myeloproliferative neoplasms (MPN) are associated with a high symptom burden and impaired quality of life (QoL), often unaided by available treatments. Physical activity has demonstrated benefits in other cancers; however, its potential has yet to be explored in MPN. This randomized controlled trial aimed to evaluate the feasibility, acceptability, and efficacy of a supervised exercise program for patients with MPN based on longitudinal assessment of symptom burden, QoL, and clinical/inflammatory markers (C-reactive protein, erythrocyte sedimentation rate, ferritin, lactate dehydrogenase [LDH], and serum cytokines). Patients with MPN (n = 55) were randomized 3:2 to a 12-week home-based exercise intervention (flexibility/resistance/aerobics) supervised by a kinesiologist vs waitlist control. Measures included patient-reported outcome questionnaires, peripheral blood sampling, and postintervention interviews with participants. Forty-seven patients completed the trial (FIT group, n = 26; control group, n = 21). Median age was 66 years (range, 27-86), and 60% were female. All feasibility benchmarks were met, with 88% of participants satisfied and 92% with intent to continue an exercise program on a regular basis. A significant reduction in LDH was observed in FIT patients compared with controls (-14.5 U/L vs +4.0 U/L; P = .03). Patients interviewed described positive effects of the intervention on symptoms and would unanimously recommend the program to others with MPN. In this pilot study, supervised exercise was feasible, acceptable, and showed potential benefits on inflammatory/disease markers.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.